Trial Profile
African-American Pharmacogenetics
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms AA-Genetic
- 14 Mar 2012 Planned End Date added to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 14 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Aug 2011 New trial record